Delivering mitochondrial health
Abliva will attend the virtual conference Mitochondrial Medicine - Therapeutic Development, organized by the Wellcome Connecting Science located at the Wellcome Genome Campus in the UK, on 30 Nov - 2 […]
Abliva will attend and present at the Mitochondria-Targeted Drug Development Summit in Boston, MA, USA. The event will be held on 22 - 24 February 2022. CEO Ellen Donnelly will […]
Abliva will participate at the United Mitochondrial Disease Foundation's Mitochondrial Medicine Symposium in Phoenix, Arizona. Abliva's CMO, Magnus Hansson, will participate in a panel discussion on clinical trials together with […]
On June 29-30, Abliva will participate at Bioblast 2022: Inaugural Conference of Bioenergetics Communications in Innsbruck, Austria. Abliva's Communications Officer & Lab Manager, Eleonor Åsander Frostner, will present a summary […]
In September, Abliva will attend mitoNice, an international congress dedicated to Mitochondrial Medicine.
In October, Abliva will attend the Italian patient organization Mitocon's annual Mitochondrial Diseases Conference in Rome, Italy. On October 8, Abliva's Chief Medical Officer Magnus Hansson will give the talk: […]
In late November, Abliva will attend the annual scientific conference Mitochondrial Medicine - Therapeutic Development in Hinxton, UK. Abliva's Chief Medical Officer, Magnus Hansson, will present a poster on one of the […]
In June, Abliva will attend this year's edition of Euromit - the international conference on mitochondrial disease. The meeting takes place in Bologna, Italy, and gathers researchers, clinicians, and patients for […]
In late June, Abliva will be attending this year's international Mitochondrial Medicine Symposium, organized by US patient organization United Mitochondrial Disease Foundation. The meeting will take place in Charlotte, North Carolina […]
Abliva will participate at the 12th annual edition of 'The Future of Swedish & Danish Life Science', on September 7, 2023, in Lund, Sweden. The company's Chief Medical Officer, Magnus […]
During World Mitochondrial Disease Week, Abliva's Chief Medical Officer, Magnus Hansson, will present the company at the Cure Mito Foundation's Empower & Inspire - 2nd Annual Leigh Syndrome Symposium (virtual). […]
In mid-March, Abliva will attend the 8th edition of Mitochondrial Medicine - Therapeutic Development in Hinxton, UK. This annual scientific meeting is focused on mitochondrial disorders and the search for […]
